{
  "id": "_b3144",
  "type": "VariantInterpretation",
  "variant": {
    "id": "CAR:CA022880",
    "type": "CanonicalAllele",
    "preferredCtxAllele": {
      "id": "_b226",
      "type": "ContextualAllele",
      "relatedCanonicalAllele": "CanAll121",
      "alleleName": "NM_024422.3(DSC2): c.631-2A>G (p.?)"
    }
  },
  "condition": [
    {
      "id": "_b4173",
      "type": "GeneticCondition",
      "disease": [
        {
          "id": "Orphanet:247",
          "type": "Disease",
          "label": "arrhythmogenic right ventricular cardiomyopathy"
        }
      ],
      "modeOfInheritance": {
        "id": "HP:0000006",
        "type": "ModeOfInheritance",
        "label": "Autosomal Dominant"
      }
    }
  ],
  "outcome": {
    "id": "LN:LA26332-9",
    "type": "Significance",
    "label": "Likely Pathogenic"
  },
  "assertionMethod": {
    "id": "SEPIO-CG:99200",
    "type": "AssertionMethod",
    "description": "ACMG ISV guidelines 2015",
    "url": "https://www.acmg.net/docs/Standards_Guidelines_for_the_Interpretation_of_Sequence_Variants.pdf",
    "version": "1.0",
    "scoringAlgorithm": {
      "id": "SEPIO-CG:99300",
      "type": "ScoringAlgorithm",
      "description": "This is the description of how the weighting of the satisfied criterion are typically evaluated to arrive at a specific clinical significance."
    }
  },
  "evidenceLine": [
    {
      "id": "_b2220",
      "type": "EvidenceLine",
      "evidenceItem": [
        {
          "id": "_b3460",
          "type": "CriterionAssessment",
          "criterion": {
            "id": "SEPIO-CG:99022",
            "type": "Criterion",
            "label": "PVS1",
            "description": "null variant (nonsense, frameshift, canonical Â±1 or 2 splice sites, initiation codon, single or multiexon deletion) in a gene where LOF is a known mechanism of disease",
            "defaultStrength": {
              "id": "SEPIO:0000220",
              "type": "EvidenceLineStrength",
              "label": "Pathogenic Very Strong"
            },
            "comments": "The two main concerns for applying this rule is:\na. Is LOF an established disease mechanism?\nb. Is LOF actually occurring?"
          },
          "variant": {
            "id": "CAR:CA022880",
            "type": "CanonicalAllele",
            "preferredCtxAllele": {
              "id": "_b226",
              "type": "ContextualAllele",
              "relatedCanonicalAllele": "CanAll121",
              "alleleName": "NM_024422.3(DSC2): c.631-2A>G (p.?)"
            }
          },
          "condition": [
            {
              "id": "_b4145",
              "type": "GeneticCondition",
              "disease": [
                {
                  "id": "Orphanet:247",
                  "type": "Disease",
                  "label": "arrhythmogenic right ventricular cardiomyopathy"
                }
              ]
            }
          ],
          "outcome": {
            "id": "SEPIO:0000223",
            "type": "CriterionEvaluation",
            "label": "Met"
          },
          "evidenceLine": [
            {
              "id": "_b2202",
              "type": "EvidenceLine",
              "evidenceItem": [
                {
                  "id": "_b3371",
                  "type": "AlleleMolecularConsequence",
                  "contextualAllele": {
                    "id": "_b226",
                    "type": "ContextualAllele",
                    "relatedCanonicalAllele": "CanAll121",
                    "alleleName": "NM_024422.3(DSC2): c.631-2A>G (p.?)"
                  },
                  "consequence": {
                    "id": "SO:0001629",
                    "type": "MolecularConsequence",
                    "label": "splice-site variant"
                  },
                  "description": "This variant occurs in the invariant region (+/- 1,2) of the splice consensus sequence and in vitro studies confirmed that it leads to aberrant splicing and reduced DSC2 protein levels (Heuser 2006 PMID: 17186466)."
                },
                {
                  "id": "_b3372",
                  "type": "ConditionMechanism",
                  "mechanism": {
                    "id": "SO:0002054",
                    "type": "Mechanism",
                    "label": "loss of function variant"
                  },
                  "condition": {
                    "id": "_b4145",
                    "type": "GeneticCondition",
                    "disease": [
                      {
                        "id": "Orphanet:247",
                        "type": "Disease",
                        "label": "arrhythmogenic right ventricular cardiomyopathy"
                      }
                    ]
                  },
                  "mechanismConfidence": {
                    "id": "SEPIO:0000269",
                    "type": "ConditionMechanismStrength",
                    "label": "established"
                  },
                  "gene": {
                    "id": "HGNC:3036",
                    "type": "Gene",
                    "geneSymbol": "DSC2"
                  },
                  "description": "Splice and other loss-of-function variants in DSC2 have been reported in individuals with ARVC (http://arvcdatabase.info/)."
                }
              ]
            }
          ],
          "contribution": [
            {
              "type": "Contribution",
              "agent": {
                "id": "Agent007",
                "type": "Agent",
                "label": "Stefan DiMarino"
              },
              "contributionDate": "01/17/17 9:12 AM",
              "contributionRole": {
                "id": "SEPIO:0000154",
                "type": "ContributoryRole",
                "label": "assessor role"
              }
            }
          ],
          "description": "This variant occurs in the invariant region (+/- 1,2) of the splice consensus sequence and in vitro studies confirmed that it leads to aberrant splicing and reduced DSC2 protein levels (Heuser 2006 PMID: 17186466). Splice and other loss-of-function variants in DSC2 have been reported in individuals with ARVC (http://arvcdatabase.info/)."
        }
      ],
      "evidenceStrength": {
        "id": "SEPIO:0000220",
        "type": "EvidenceLineStrength",
        "label": "Pathogenic Very Strong"
      },
      "contribution": [
        {
          "type": "Contribution",
          "agent": {
            "id": "Agent007",
            "type": "Agent",
            "label": "Stefan DiMarino"
          },
          "contributionDate": "01/17/17 9:12 AM",
          "contributionRole": {
            "id": "SEPIO:0000154",
            "type": "ContributoryRole",
            "label": "assessor role"
          }
        }
      ]
    },
    {
      "id": "_b2221",
      "type": "EvidenceLine",
      "evidenceItem": [
        {
          "id": "_b3468",
          "type": "CriterionAssessment",
          "criterion": {
            "id": "SEPIO-CG:99028",
            "type": "Criterion",
            "label": "PM2",
            "description": "Absent from controls (or at extremely low frequency if recessive) (Table 6) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium",
            "defaultStrength": {
              "id": "SEPIO:0000216",
              "type": "EvidenceLineStrength",
              "label": "Pathogenic Moderate"
            },
            "comments": "Some groups are allowing to rule to be used if even not 100% absent\nFor instance, Cardio has allowed PM2 to be used if MAF is <0.05% with 95% CI if\nCI lower is ~0.00% (at 2 decimal places) AND CI upper is below 0.05%\n Caveat: Population data for insertions/deletions may be poorly called by next-generation sequencing"
          },
          "variant": {
            "id": "CAR:CA022880",
            "type": "CanonicalAllele",
            "preferredCtxAllele": {
              "id": "_b226",
              "type": "ContextualAllele",
              "relatedCanonicalAllele": "CanAll121",
              "alleleName": "NM_024422.3(DSC2): c.631-2A>G (p.?)"
            }
          },
          "outcome": {
            "id": "SEPIO:0000223",
            "type": "CriterionEvaluation",
            "label": "Met"
          },
          "evidenceLine": [
            {
              "id": "_b2206",
              "type": "EvidenceLine",
              "evidenceItem": [
                {
                  "id": "_b3469",
                  "type": "AlleleFrequency",
                  "ascertainment": {
                    "id": "SEPIO:0000332",
                    "type": "Ascertainment",
                    "label": "ExAc ascertainment method"
                  },
                  "population": {
                    "id": "BROAD-population-type:nfe",
                    "type": "Population",
                    "label": "Non-Finnish European"
                  },
                  "allele": {
                    "id": "CAR:CA022880",
                    "type": "CanonicalAllele",
                    "preferredCtxAllele": {
                      "id": "_b226",
                      "type": "ContextualAllele",
                      "relatedCanonicalAllele": "CanAll121",
                      "alleleName": "NM_024422.3(DSC2): c.631-2A>G (p.?)"
                    }
                  },
                  "alleleCount": 1,
                  "alleleNumber": 66564,
                  "alleleFrequency": 1.5e-05,
                  "homozygousAlleleIndividualCount": 0
                }
              ]
            }
          ],
          "contribution": [
            {
              "type": "Contribution",
              "agent": {
                "id": "Agent001",
                "type": "Agent",
                "label": "Harry Stevenson"
              },
              "contributionDate": "03/07/2017 5:22 PM",
              "contributionRole": {
                "id": "SEPIO:0000154",
                "type": "ContributoryRole",
                "label": "assessor role"
              }
            }
          ],
          "description": "This variant has been reported in 1/66564 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs397514042)."
        }
      ],
      "evidenceStrength": {
        "id": "SEPIO:0000216",
        "type": "EvidenceLineStrength",
        "label": "Pathogenic Moderate"
      },
      "contribution": [
        {
          "type": "Contribution",
          "agent": {
            "id": "Agent001",
            "type": "Agent",
            "label": "Harry Stevenson"
          },
          "contributionDate": "03/07/2017 5:22 PM",
          "contributionRole": {
            "id": "SEPIO:0000154",
            "type": "ContributoryRole",
            "label": "assessor role"
          }
        }
      ]
    }
  ],
  "contribution": [
    {
      "type": "Contribution",
      "agent": {
        "id": "Agent006",
        "type": "Agent",
        "label": "CSER classifier #6"
      },
      "contributionDate": "6/26/2015 12:06 PM",
      "contributionRole": {
        "id": "SEPIO:0000331",
        "type": "ContributoryRole",
        "label": "interpreter role"
      }
    }
  ],
  "description": "The c.631-2A>G variant in DSC2 has been reported in 1 Caucasian individual with ARVC (Heuser 2006). This variant has also been identified by our laboratory in 2 individuals (1 with ARVC and 1 with LVNC). This variant has been reported in 1/66564 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs397514042). This variant occurs in the invariant region (+/- 1,2) of the splice consensus sequence and in vitro studies confirmed that it leads to aberrant splicing and reduced DSC2 protein levels (Heuser 2006). Splice and other loss-of-function variants in DSC2 have been reported in individuals with ARVC (http://arvcdatabase.info/). In summary, although additional studies are required to fully establish its clinical significance, the c.631-2A>G variant is likely pathogenic.",
  "@context": "http://datamodel.clinicalgenome.org/interpretation/json/context"
}
